This README.txt file was generated on 2021-09-09 by JAIME A. YANEZ GENERAL INFORMATION 1. Title of Dataset: Medicinal plants COVID-19 Cusco English 2. Author Information A. Principal Investigator Contact Information Name: Jaime A. Yanez Institution: Universidad Norbert Wiener Address: Lima, Peru Email: jaime.yanez@uwiener.edu.pe B. Associate or Co-investigator Contact Information Name: Magaly Villena-Tejada Institution: Universidad Nacional de San Antonio Abad del Cusco Address: Cusco, Peru Email: magaly.villena@unsaac.edu.pe C. Alternate Contact Information Name: Christian R. Mejia Institution: Universidad Continental Address: Lima, Peru Email: cmejia@continental.edu.pe 3. Date of data collection: 2020-08-31 to 2020-09-20 4. Geographic location of data collection: Cusco, Peru 5. Information about funding sources that supported the collection of the data: the Universidad Nacional de San Antonio Abad del Cusco (UNSAAC) grant R-446-2020-UNSAAC SHARING/ACCESS INFORMATION 1. Licenses/restrictions placed on the data: No restrictions 2. Links to publications that cite or use the data: 10.1371/journal.pone.0257165 (published paper), 10.1101/2021.05.26.21257890 (pre-print) 3. Links to other publicly accessible locations of the data: 4. Links/relationships to ancillary data sets: 5. Was data derived from another source? No A. If yes, list source(s): 6. Recommended citation for this dataset: Villena-Tejada, Magaly et al. (2021), Use of medicinal plants for COVID-19 prevention and respiratory symptom treatment during the pandemic in Cusco, Peru: A cross-sectional survey, Dryad, Dataset, https://doi.org/10.5061/dryad.ghx3ffbpg DATA & FILE OVERVIEW 1. File List: Medicinal plants COVID-19 Cusco English.csv 2. Relationship between files, if important: 3. Additional related data collected that was not included in the current data package: Occupation and Education Level data is available upon request 4. Are there multiple versions of the dataset? No A. If yes, name of file(s) that was updated: i. Why was the file updated? ii. When was the file updated? METHODOLOGICAL INFORMATION 1. Description of methods used for collection/generation of data: We conducted an online cross-sectional multicenter survey, which was initially evaluated by 10 expert judges using Aiken's V. After including the experts’ observations, a pilot study was performed (from August 16 to 24, 2020) with 336 respondents in in five districts of Cusco, Peru. The pilot data was used to calculate the minimal sample size necessary for the actual study. It was determined that a minimum sample size of 1,530 was necessary to achieve a minimum percentage difference of 2.5% (49.0% versus 51.5%), a statistical power of 80%, and a confidence level of 95%. The sample size was calculated using power analysis. The actual survey consisted of an online questionnaire that was sent via WhatsApp, Messenger, and Facebook. The shared questionnaire was made anonymous ensuring data confidentiality and reliability. The survey was performed from August 31 to September 20, 2020 after approximately 9 months of lockdown and social distancing measures in Peru due to the COVID-19 outbreak. At the beginning of the survey (August 31) the number of COVID-19 confirmed cases was 652,037 and 28,944 deaths, while at the end of the survey (September 20) the confirmed cases increased to 772,896 and the deaths increased to 31,474. We surveyed general public who were adults of both genders aged 20 to 70 years in five districts of Cusco, Peru with high-risk COVID-19 transmission according to the Epidemiological Alert AE-017-2020. The five districts were Cusco, San Jerónimo, San Sebastián, Santiago, and Wanchaq. Participants were recruited by the research team of the Universidad Nacional de San Antonio Abad del Cusco. There were no exclusions because we implemented that it was mandatory to reply all the answers. Therefore, we only obtained complete and high-quality answers, which was verified by a data quality check. 2. Methods for processing the data: Data analysis was done in STATA version 14 (Stata Corp) with a significance level set at p<0.05. Descriptive analysis of categorical (demographic) variables was performed to show the frequency and percentage of each response. The results were summarized in unidimensional tables to identify the medicinal plants that are most used by the respondents. Chi-square test was performed in the bivariate analysis to determine the association between the studied variables. Generalized linear models were used in the multivariate analysis using the Poisson family, the log-link function, and the models for variances of robust models and the district of residence as a cluster, thereby obtaining the prevalence ratios (PR). The 95% confidence intervals (CI) and p-value < 0.05 were considered as the limit of statistical significance. 3. Instrument- or software-specific information needed to interpret the data: The survey included 11 questions, 5 were demographic questions, 2 were related to the use of medicinal plants as preventive or treatment of respiratory symptoms related to COVID-19, 2 were related to the diagnosis of COVID-19 in themselves and the close environment (family and friends), and the last 2 questions related to the medicinal plants were used and to what respiratory symptom(s) they were used for. The demographic questions included sex, age, education level, occupation or professional activity and the district of residence in Cusco. The respondents were asked to indicate if during the COVID-19 lockdown they used medicinal plants to prevent or treat respiratory symptoms related to COVID-19. Then, the respondents were asked if they were diagnosed with COVID-19, and if any family member or friend was diagnosed with COVID-19. The respondents were asked to select from a list of 17 selected medicinal plants the ones they have used to prevent or treat COVID-19 related respiratory symptoms. The selection of the medicinal plants was based on ethnopharmacological reports of the ones used for respiratory problems in Peru. Finally, the respondents were asked to select the symptom(s) why they consumed any of the medicinal plants indicated on the previous question. The symptoms included cough, sore throat, fever, headache or malaise. Loss of taste or smell, nausea/vomiting and diarrhea were not included. The selected symptoms relate to the most common COVID-19 symptoms reported by the Center of Disease Control and Prevention (CDC). 4. Standards and calibration information, if appropriate: 5. Environmental/experimental conditions: 6. Describe any quality-assurance procedures performed on the data: There were no exclusions because we implemented that it was mandatory to reply all the answers. Therefore, we only obtained complete and high-quality answers, which was verified by a data quality check. 7. People involved with sample collection, processing, analysis and/or submission: Magaly Villena-Tejada, Ingrid Vera-Ferchau, Anahí Cardona-Rivero, Rina Zamalloa-Cornejo, Maritza Quispe-Florez, Zany Frisancho-Triveño, Rosario C. Abarca-Meléndez, Susan G. Alvarez-Sucari, Christian R. Mejia, Jaime A. Yañez DATA-SPECIFIC INFORMATION FOR: Medicinal plants COVID-19 Cusco English.csv 1. Number of variables: 42 2. Number of cases/rows: 1747 3. Variable List: id, respondent number Use for prevention, do you use medicinal plants to prevent respiratory symptoms related to COVID-19 during the pandemic?, yes/no Use for treatment, do you use medicinal plants to treat respiratory symptoms related to COVID-19 during the pandemic?, yes/no Age, age of respondent at time of survey, years Gender, gender of respondent, 0 = male, 1 = female District, district in Cusco where the respondent lives, 1 = Cusco, 2 = San Jerónimo, 3 = San Sebastián, 4 = Santiago, 5 = Wanchaq COVID-19, have you been diagnosed with COVID-19?, yes/no Family member or friend with COVID-19, Have a family member or friend been diagnosed with COVID-19?, yes/no eucaliptus_when you use, what symptom did you use eucaliptus for? ginger_when you use, what symptom did you use ginger for? garlic_when you use, what symptom did you use garlic for? coca_when you use, what symptom did you use coca for? munia_when you use, what symptom did you use munia for? matico_when you use, what symptom did you use matico for? chamomile_when you use, what symptom did you use chamomile for? rosemary_when you use, what symptom did you use rosemary for? oregano_when you use, what symptom did you use oregano for? lemon balm_when you use, what symptom did you use lemon balm for? geranium_when you use, what symptom did you use geranium for? thyme_when you use, what symptom did you use thyme for? panty_when you use, what symptom did you use panty for? ketoketo_when you use, what symptom did you use ketoketo for? sage_when you use, what symptom did you use sage for? wirawira_when you use, what symptom did you use wirawira for? asmachilca_when you use, what symptom did you use asmachilca for? eucaliptus, which medicinal plan have you used to prevent or treat respiratory symptoms related to COVID-19 during the pandemic?, yes/no ginger, which medicinal plan have you used to prevent or treat respiratory symptoms related to COVID-19 during the pandemic?, yes/no garlic, which medicinal plan have you used to prevent or treat respiratory symptoms related to COVID-19 during the pandemic?, yes/no coca, which medicinal plan have you used to prevent or treat respiratory symptoms related to COVID-19 during the pandemic?, yes/no munia, which medicinal plan have you used to prevent or treat respiratory symptoms related to COVID-19 during the pandemic?, yes/no matico, which medicinal plan have you used to prevent or treat respiratory symptoms related to COVID-19 during the pandemic?, yes/no chamomile, which medicinal plan have you used to prevent or treat respiratory symptoms related to COVID-19 during the pandemic?, yes/no rosemary, which medicinal plan have you used to prevent or treat respiratory symptoms related to COVID-19 during the pandemic?, yes/no oregano, which medicinal plan have you used to prevent or treat respiratory symptoms related to COVID-19 during the pandemic?, yes/no lemon balm, which medicinal plan have you used to prevent or treat respiratory symptoms related to COVID-19 during the pandemic?, yes/no geranium, which medicinal plan have you used to prevent or treat respiratory symptoms related to COVID-19 during the pandemic?, yes/no thyme, which medicinal plan have you used to prevent or treat respiratory symptoms related to COVID-19 during the pandemic?, yes/no panty, which medicinal plan have you used to prevent or treat respiratory symptoms related to COVID-19 during the pandemic?, yes/no ketoketo, which medicinal plan have you used to prevent or treat respiratory symptoms related to COVID-19 during the pandemic?, yes/no sage, which medicinal plan have you used to prevent or treat respiratory symptoms related to COVID-19 during the pandemic?, yes/no wirawira, which medicinal plan have you used to prevent or treat respiratory symptoms related to COVID-19 during the pandemic?, yes/no asmachilca, which medicinal plan have you used to prevent or treat respiratory symptoms related to COVID-19 during the pandemic?, yes/no 4. Missing data codes: Missing data = blank 5. Specialized formats or other abbreviations used: